Drug-associated agranulocytosis: 20 Years of reporting in The Netherlands (1974-1994)

American Journal of Hematology

Volumn 57, Issue 3, 1998, Pages 206-211

  Van Der Klauw, M M ^a,b   Wilson, J H P ^b   Stricker, B H Ch ^a,b  

^a Drug Safety Unit   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adverse drug reaction; Agranulocytosis; Dipyrone; Mianserine; Sulphasalazine

Indexed keywords

AMINOPHENAZONE; CIMETIDINE; COTRIMOXAZOLE; DIPYRONE; GENTAMICIN; INDOMETACIN; METHYLDOPA; MIANSERIN; PENICILLAMINE; PENICILLIN G; PHENYLBUTAZONE; PROPYLTHIOURACIL; SALAZOSULFAPYRIDINE; SPIRONOLACTONE; THIAMAZOLE; THIOURACIL DERIVATIVE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; NEUTROPENIA; PRIORITY JOURNAL; SYMPTOM;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGRANULOCYTOSIS; DRUG MONITORING; FEMALE; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NETHERLANDS; NEUTROPENIA; PHARMACEUTICAL PREPARATIONS;

EID: 0031935228     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199803)57:3<206::AID-AJH4>3.0.CO;2-Z     Document Type: Article

References (43)

1. Madison FW, Squier TL: The etiology of primary granulocytopenia (agranulocytic angina). JAMA 102:755-759, 1934.
2. Böttiger LE, Furhoff AK, Holmberg L: Drug-induced blood dyscrasias: A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand 205:457-461, 1979.
3. Van der Klauw MM: "The Nationwide Case-Cohort Study in Pharmacoepidemiology: A Study of Iatrogenic Anaphylaxis and Agranulocytosis." Ph D Thesis, Eramus University, Rotterdam, 1997.
4. Heimpel H: Drug-induced agranulocytosis. Med Toxicol Adverse Drug Exp 3:449-462, 1988.
5. Murphy MF, Riordan T, Minchinton RM, Chapman JF, Amess JAL, Shaw EJ, Waters AH: Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br J Haematol 55:155-160, 1983.
6. Mc Guigan JE: A consideration of the adverse effects of cimetidine. Gastroenterol 80:181-192, 1981.
7. Nygard N, Starkebaum G: Naproxen and agranulocytosis. JAMA 257: 1732, 1987.
8. Guffy MM, Goeken NE, Burns CP: Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Arch Int Med 144:1687-1688, 1984.
9. Toth EL, Mant MJ, Shivji S, Ginsberg J: Propylthiouracil-induced agranulocytosis: An unusual presentation and a possible mechanism. Am J Med 85:725-772, 1988.
10. Jungi WF, Fischer J, Senn HJ, Hartlapp J, Pöldinger W, Kunz H, Krupp P: Gehäufte durch Clozapin (Leponex) induzierte Agranulozytosen in der Ostschweiz? Schweiz Med Wschr 107:1861-1864, 1977.
11. Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva I: Clozapine and agranulocytosis. Lancet ii:611, 1975.
12. Alvir JMaJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA: Clozapine-induced agranulocytosis: Incidence and risk factors in the United States. N Engl J Med 329:162-167, 1993.
13. Murphy MF, Metcalfe P, Grint PCA, Green AR, Knowles S, Amess JAL, Waters AH: Cephalosporin-induced immune neutropenia. Br J Haematol 59:9-14, 1985.
14. Freed JS, Reiner MA: Septic complications of procainamide-induced agranulocytosis: Report of two cases. Mnt Sinai J Med 55:194-197, 1988.
15. Graham WR: Adverse effects of dapsone. Int J Derm 14:494-500, 1975.
16. Liozon F, Fourgnaud-Gaillard S, Bordessoule D, Roussel H, Vidal E, Weinbreck P, Liozon E, Cransac M: Agranulocytoses à la dapsone: A propos de 3 observations. Revue de la littérature. Ann Med Interne 139:469-475, 1988.
17. Lacotte J, Perrin C, Mosquet B, Moulin M, Bazin C: Agranulocytose au paracétamol: A propos d'un cas. Therapie 45:438-439, 1990.
18. Lesesve J-F, Callat M-P, Lenormand B, Monconduit M, Noblet C, Moore N, Caron F, Humbert G, Stamatoullas A, Tilly H: Hematological toxicity of ticlopidine. Am J Hematol 47:149-150, 1994.
19. Van Leeuwen R: Agranulocytose tijdens het gebruik van aprindine. Ned T Geneeskd 120:1549-1550, 1976.
20. Van Leeuwen R, Meyboom RHB: Agranulocytosis and aprindine. Lancet ii:1137, 1976.
21. Stricker BHCh, Oei TT: Agranulocytosis caused by spironolactone. Br Med J 289:731, 1984.
22. Claas FHJ, de Fraiture WH, Meyboom RHB: Thrombopénie causée par des anticorps induits par la Ticlopidine. Nouv Rev Fr Hematol 26:323, 1984.
23. Fibbe WE, Claas FHJ, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RHB, Falkenburg JHF: Agranulocytosis induced by propylthiouracil: Evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 64:363-373, 1986.
24. Stricker BHCh, Meyboom RHB, Bleeker PA, Van Wieringen K: Blood disorders associated with pirenzepine. Br Med J 293:1074, 1986.
25. Van der Klauw MM, Janssen JC, Stricker BHCh: Agranulocytosis probably induced by trazodone. Am J Psychiatry 150:1563-1564, 1993.
26. Ottervanger JP, Kapelle JW, Claas FHJ, Stricker BHCh: Omeprazole-associated agranulocytosis. Eur J Haematol 54:279-280, 1995.
27. Stricker BHCh, Barendregt JNM, Claas FHJ: Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol 19:102-104, 1985.
28. Böttiger LE, Westerholm B: Drug-induced blood dyscrasias in Sweden. Br Med J 3:339-343, 1973.
29. Danielson DA, Douglas III SW, Herzog P, Jick H, Porter J: Drug-induced blood disorders. JAMA 252:3257-3260, 1984.
30. Arneborn P, Palmblad J: Drug-induced neutropenia in the Stockholm region 1973-75: Frequency and causes. Acta Med Scand 204:283-286, 1978.
31. Arneborn P, Palmblad J: Drug-induced neutropenias in the Stockholm region 1976-1977. Acta Med Scand 206:241-243, 1979.
32. Arneborn P, Palmblad J: Drug-induced neutropenia: A survey for Stockholm 1973-1978. Acta Med Scand 212:289-292, 1982.
33. The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749-1757, 1986.
34. The International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplastic anemia in relation to use of antithyroid drugs. Br Med J 297:262-265, 1988.
35. The International Agranulocytosis and Aplastic Anemia Study. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. Arch Intern Med 149:1036-1040, 1989.
36. Kelly JP, Kaufman DW, Shapiro S. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther 49:330-341, 1991.
37. Van Dijke CPH. Analgesic use, agranulocytosis and aplastic anemia. JAMA 257:2590, 1987.
38. Kumana CR. Analgesic use, agranulocytosis and aplastic anemia. JAMA 257:2590-2591, 1987.
39. Kramer MS, Lane DA, Hutchinson TA. Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology: A critique of the International Agranulocytosis and Aplastic Anemia Study. J Chron Dis 40:1073-1081, 1987.
40. Participants of the IAAAS. Reply to Kramer, Lane and Hutchinson: The International Agranulocytosis and Aplastic Anemia Study. J Chron Dis 40:1083-1085, 1987.
41. Kramer MS. The International Agranulocytosis and Aplastic Anemia Study (IAAAS). J Clin Epidemiol 41:613-614, 1988.
42. Participants of the IAAAS. Response. J Clin Epidemiol 41:615-616, 1988.
43. Ibánez L, Juan J, Pérez E, Carné X, Laporte JR. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: An epidemiological approach. Eur Heart J 12:639-641, 1991.